About Biophytis
Biophytis is a company based in Romainville (France) founded in 2006.. Biophytis has raised $2.6 million across 5 funding rounds from investors including Seventure Partners and CM-CIC Capital Prive. The company has 20 employees as of December 31, 2024. Biophytis offers products and services including BIO101 and Macuneos (BIO201). Biophytis operates in a competitive market with competitors including Jazz Pharmaceuticals, Biogen, Biological E, Vir Biotechnology and Neurocrine, among others.
- Headquarter Romainville, France
- Employees 20 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Biophytis Sa
-
Annual Revenue
$0 (USD)0as on Dec 31, 2024
-
Net Profit
$-10.78 M (USD)39.04as on Dec 31, 2024
-
EBITDA
$-9.71 M (USD)38.02as on Dec 31, 2024
-
Total Equity Funding
$2.6 M (USD)
in 5 rounds
-
Latest Funding Round
$38.22 M (USD), Post-IPO
Jun 18, 2021
-
Investors
Seventure Partners
& 1 more
-
Employee Count
20
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Biophytis
Biophytis is a publicly listed company on the EURONEXT with ticker symbol ALBPS in France, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Biophytis
Biophytis offers a comprehensive portfolio of products and services, including BIO101 and Macuneos (BIO201). The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Oral molecule for treating sarcopenia and neuromuscular conditions.
Oral treatment for retinal diseases like macular degeneration.
Unlock access to complete
Unlock access to complete
Funding Insights of Biophytis
Biophytis has successfully raised a total of $2.6M across 5 strategic funding rounds. The most recent funding activity was a Post-IPO round of $38.22 million completed in June 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Post-IPO — $38.2M
-
First Round
First Round
(01 Oct 2012)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2021 | Amount | Post-IPO - Biophytis | Valuation |
investors |
|
| Jul, 2020 | Amount | Post-IPO - Biophytis | Valuation |
investors |
|
| Oct, 2017 | Amount | Post-IPO - Biophytis | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Biophytis
Biophytis has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Seventure Partners and CM-CIC Capital Prive. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Tech & Life Sciences focused stage agnostic VC firm investing in Europe, Asia & the US
|
Founded Year | Domain | Location | |
|
Private equity firm focused on SMEs
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Biophytis
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Biophytis
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Biophytis Comparisons
Competitors of Biophytis
Biophytis operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Jazz Pharmaceuticals, Biogen, Biological E, Vir Biotechnology and Neurocrine, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| domain | founded_year | HQ Location |
Therapies for neurodegenerative and immunology disorders are developed.
|
|
| domain | founded_year | HQ Location |
Vaccines and therapeutics for multiple diseases are developed and marketed.
|
|
| domain | founded_year | HQ Location |
Developer of therapeutics for the treatment of infectious diseases
|
|
| domain | founded_year | HQ Location |
Developer of small molecule therapeutics for endocrine and CNS disorders
|
|
| domain | founded_year | HQ Location |
Small molecule drugs for rare diseases are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Biophytis
Frequently Asked Questions about Biophytis
When was Biophytis founded?
Biophytis was founded in 2006 and raised its 1st funding round 6 years after it was founded.
Where is Biophytis located?
Biophytis is headquartered in Romainville, France. It is registered at Romainville, Ile-de-france, France.
Is Biophytis a funded company?
Biophytis is a funded company, having raised a total of $2.6M across 5 funding rounds to date. The company's 1st funding round was a Post-IPO of $12.26M, raised on Oct 01, 2012.
How many employees does Biophytis have?
As of Dec 31, 2024, the latest employee count at Biophytis is 20.
What does Biophytis do?
The company was founded in 2006 and is headquartered in Romainville, France. Focus is placed on the biotechnology sector, where treatments for neuromuscular and age-related conditions are developed. Sarconeos (BIO101), an oral small molecule, is advanced for sarcopenia and Duchenne muscular dystrophy. Macuneos (BIO201) is pursued for retinal disorders such as dry age-related macular degeneration and Stargardt disease. Operations center on clinical-stage drug candidates.
Who are the top competitors of Biophytis?
Biophytis's top competitors include Jazz Pharmaceuticals, Vaxcyte and PTC Therapeutics.
What products or services does Biophytis offer?
Biophytis offers BIO101 and Macuneos (BIO201).
Is Biophytis publicly traded?
Yes, Biophytis is publicly traded on EURONEXT under the ticker symbol ALBPS.
Who are Biophytis's investors?
Biophytis has 2 investors. Key investors include Seventure Partners, and CM-CIC Capital Prive.
What is Biophytis's ticker symbol?
The ticker symbol of Biophytis is ALBPS on EURONEXT.